Showing results (71-80 of 252) with videos related to
Sort By:
Pageof 26
Vaccine|December 18, 2004
Lack of toxicity of therapy-induced T cell responses against the universal tumour antigen survivinKerstin Otto, Mads Hald Andersen, Andreas Eggert, et al.Plos One|December 21, 2016
(GT)n Repeat Polymorphism in Heme Oxygenase-1 (HO-1) Correlates with Clinical Outcome after Myeloablative or Nonmyeloablative Allogeneic Hematopoietic Cell TransplantationTania Køllgaard, Brian Kornblit, Jesper Petersen, et al.The Journal of Investigative Dermatology|November 11, 2009
Adoptive cell transfer in the treatment of metastatic melanomaPer thor Straten, Jürgen C BeckerCytotherapy|March 25, 2011
Bimodal ex vivo expansion of T cells from patients with head and neck squamous cell carcinoma: a prerequisite for adoptive cell transferNiels Junker, Mads Hald Andersen, Lynn Wenandy, et al.Oncoimmunology|May 8, 2015
Indoleamine 2,3-dioxygenase vaccinationMads Hald Andersen, Inge Marie SvaneCurrent Cancer Drug Targets|March 25, 2014
The expression, function and targeting of haem oxygenase-1 in cancerMads Duus Hjortsø, Mads Hald AndersenCancers|October 22, 2020
Healthy Donors Harbor Memory T Cell Responses to RAS Neo-AntigensMorten Orebo Holmström, Mads Hald AndersenPlos One|September 10, 2009
The immune system strikes back: cellular immune responses against indoleamine 2,3-dioxygenaseRikke Baek Sørensen, Linda Berge-Hansen, Niels Junker, et al.Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society|December 18, 2012
Effector CD4 and CD8 T cells and their role in the tumor microenvironmentSine Hadrup, Marco Donia, Per Thor StratenOncoimmunology|May 8, 2015
Tryptophan 2,3-dioxygenase (TDO)-reactive T cells differ in their functional characteristics in health and cancerMads Duus Hjortsø, Stine Kiaer Larsen, Per Kongsted, et al.Pageof 26